Evidence map›Paper›PMID 34301163›Full record

ArticleWestern journal of nursing research2022

Polysubstance Use, Mood Disorders, and Chronic Conditions With Anxiety in Opioid Patients.

Sophia Liu, Christian Nwabueze, Yue Pan, Suzy Mascaro Walter, Brenda Su, Chun Xu, Erin L Winstanley, Kesheng Wang

Open access · greenAbstract read
In one paragraph

Article in Western journal of nursing research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 1 country.

Sophia LiuCollege of Literature, Science, and the Arts, University of Michigan, Ann Arbor, MI, USA.
Christian NwabuezeDepartment of Biostatistics and Epidemiology, College of Public Health, East Tennessee State University, Johnson City, TN, USA.
Yue PanDepartment of Public Health Sciences, Miller School of Medicine, University of Miami, Miami, FL, USA.
Suzy Mascaro WalterDepartment of Family and Community Health, School of Nursing, Health Sciences Center, West Virginia University, Morgantown, WV, USA.
Brenda SuDepartment of Health and Biomedical Sciences, College of Health Professions, University of Texas Rio Grande Valley, Brownsville, TX, USA.
Chun XuDepartment of Health and Biomedical Sciences, College of Health Professions, University of Texas Rio Grande Valley, Brownsville, TX, USA.
Erin L WinstanleyDepartment of Behavioral Medicine & Psychiatry, Rockefeller Neuroscience Institute, School of Medicine, West Virginia University, Morgantown, WV, USA.
Kesheng WangDepartment of Family and Community Health, School of Nursing, Health Sciences Center, West Virginia University, Morgantown, WV, USA.ORCID 0000-0001-7118-3877
West Virginia University · USThe University of Texas Rio Grande Valley · USEast Tennessee State University · USUniversity of Miami · USUniversity of Michigan · US

Funding

Project-008UG1DA049436 · NIDA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Jane M. Liebschutz, Erin L Winstanley · 2019 to 2026
$10.5M
NIDA NIH HHS UG1 DA049436
6 · The paper itself

Abstract

This study examined the associations of polysubstance use, mood disorders, and chronic conditions with the history of anxiety disorder among patients with opioid use disorder (OUD). We performed a secondary analysis of the baseline data from a clinical trial including 1,645 individuals with OUD, of which 513 had anxiety disorder. Substance use disorders (SUDs) included alcohol, amphetamines, cannabis, cocaine, and sedative use disorders. Mood disorders included major depressive disorder (MDD) and bipolar disorder (BD). Chronic conditions were allergies, gastrointestinal problem(s), skin problem(s), and hypertension. Sedative use disorder, MDD, BD, skin problems, and hypertension were significantly associated with anxiety disorder (

Indexed as

HypertensionMajor Depressive DisorderOpioid-Related DisordersSubstance-Related DisordersAnalgesics, OpioidAnxietyAnxiety DisordersChronic DiseaseComorbidityHumansHypnotics and SedativesMood DisordersAnalgesics, OpioidHypnotics and SedativesAnxiety disordersMood disordersMultiple chronic conditionsOpioid use disorderPolysubstance use

Identifiers

PMID34301163
PMCPMC12810701
OpenAlexW3185678211

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.